These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 17530490)

  • 1. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
    Klingelhutz AJ
    Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
    Kelland L
    Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase and cancer.
    Harley CB; Kim NW
    Important Adv Oncol; 1996; ():57-67. PubMed ID: 8791128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomeres, telomerase and cancer: is the magic bullet real?
    Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
    Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative lengthening of telomeres in mammalian cells.
    Henson JD; Neumann AA; Yeager TR; Reddel RR
    Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomeres and telomerase: Biological and clinical importance in dogs.
    Nasir L
    Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere lengthening in telomerase-negative cells: the ends are coming together.
    Scheel C; Poremba C
    Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of telomeres and telomerase in human cancer.
    Balasubramanian S; Singh N
    Indian J Physiol Pharmacol; 1996 Jul; 40(3):199-204. PubMed ID: 8950133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies of treating cancer by cytokine regulation of chromosome end remodelling.
    Liu JP; Nicholls C; Chen SM; Li H; Tao ZZ
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):88-92. PubMed ID: 19566820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomere and telomerase in human cancer].
    Hiyama K; Hiyama E; Ishioka S; Yamakido M
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
    Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
    Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.